NR3-R (GLP-3) — 30mg research vials
Novanta supplies NR3-R, the investigational GIP/GLP-1/glucagon triple agonist, as a lyophilized powder for laboratory research. The current posted lot report includes third-party HPLC purity results. Eligible orders target dispatch from the United States within 7 business days after payment and required verification.
- Current lot report: 99.49% HPLC purity
- Lot report posted on certifications page
- US shipping, free over $300
- Build-a-Box savings of 25% with three or more distinct items
NR3-R30MGWhat is NR3-R?
NR3-R (also referenced as LY3437943 or GLP-3) is a synthetic 39-amino-acid peptide engineered to activate three receptors at once: glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1) and the glucagon receptor. Where earlier research compounds such as semaglutide target a single pathway and tirzepatide targets two, NR3-R's triple mechanism is studied for combined effects on insulin signalling, gastric emptying and basal energy expenditure in preclinical models.
Because of that mechanism, NR3-R is one of the most requested compounds in metabolic research programs. The currently posted lot report (NRRTA30-0021) states 99.49% HPLC purity for that lot only — see our third-party testing and certifications.
NR3-R reconstitution reference
The table shows nominal concentration arithmetic for 30mg of material in different final solution volumes, assuming complete dissolution and a homogeneous solution. These are examples, not recommended preparation volumes or evidence of solvent compatibility. For concentration and sample-volume calculations, use the Novanta peptide reconstitution calculator.
| Vial | Final solution volume | Concentration |
|---|---|---|
| 30mg | 1.5 mL | 20 mg/mL |
| 30mg | 3.0 mL | 10 mg/mL |
| 30mg | 5.0 mL | 6 mg/mL |
Reference values for laboratory calculations only. Not dosing guidance for humans or animals.
Handling, storage and stability
Storage temperature, transit tolerance and prepared-solution hold time require evidence applicable to the compound, lot, solvent, container and laboratory protocol. The posted HPLC purity report does not establish shelf life, solvent compatibility or stability after preparation or shipping. No universal temperature or expiration window is established here; use documented material-specific conditions and assess handling changes before relying on a preparation in an assay.
Pair NR3-R with other research compounds
Researchers frequently run NR3-R alongside supporting compounds. Build your own kit with the Build-a-Box tool for an automatic 25% discount with three or more distinct items, or start from a prebuilt bundle on the homepage.
NR3-R research FAQ
What is NR3-R?
NR3-R is an investigational triple agonist peptide that acts on the GIP, GLP-1 and glucagon receptors. It is studied in laboratory research for its effects on metabolic pathways, appetite signalling and energy expenditure. Novanta supplies NR3-R strictly as a research chemical.
How pure is Novanta's NR3-R?
The currently posted report (lot NRRTA30-0021, ILS Laboratories) states 99.49% purity by RP-HPLC. That report does not include mass spectrometry. Results apply only to that lot; see our certifications page.
How is NR3-R reconstituted?
NR3-R is supplied as a lyophilized powder. Preparation conditions and diluent compatibility must follow documented laboratory methods for the compound and assay. As nominal arithmetic, 30mg in a final solution volume of 3mL gives 10mg/mL, assuming complete dissolution. The calculator provides concentration and sample-volume arithmetic only.
What vial sizes are available?
Novanta stocks NR3-R in 30mg vials, along with 10ml bacteriostatic water for reconstitution. Build-a-Box orders with three or more distinct items receive 25% off automatically at checkout.
How fast does Novanta ship?
Eligible in-stock orders target dispatch from the United States within 7 business days of payment confirmation and required verification. Estimates can vary; see our Shipping Policy. Shipping is free on orders over $300.
Is NR3-R approved for human use?
No. NR3-R is not approved by the FDA and is sold by Novanta for laboratory research use only. It is not for human or veterinary consumption, and Novanta is not a compounding pharmacy.
Order research-grade NR3-R
30mg vials with a posted lot report. Eligible orders target US dispatch within 7 business days after payment and required verification.
Shop NR3-R nowFor research use only. Not for human or veterinary consumption. Novanta Research is not a compounding pharmacy and makes no medical claims. All products are sold to qualified researchers for in-vitro laboratory research only.